- Home
- CELU vs PAVS Comparison
CELU vs PAVS Comparison
Compare CELU & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- PAVS
- Stock Information
- Founded
- CELU 2016
- PAVS 2004
- Country
- CELU United States
- PAVS United States
- Employees
- CELU N/A
- PAVS N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- CELU Health Care
- PAVS Health Care
- Exchange
- CELU Nasdaq
- PAVS Nasdaq
- Market Cap
- CELU 56.9M
- PAVS 68.0M
- IPO Year
- CELU N/A
- PAVS 2019
- Fundamental
- Price
- CELU $2.00
- PAVS $0.67
- Analyst Decision
- CELU Strong Buy
- PAVS
- Analyst Count
- CELU 1
- PAVS 0
- Target Price
- CELU $6.00
- PAVS N/A
- AVG Volume (30 Days)
- CELU 167.1K
- PAVS 405.4K
- Earning Date
- CELU 12-05-2025
- PAVS 08-04-2025
- Dividend Yield
- CELU N/A
- PAVS N/A
- EPS Growth
- CELU N/A
- PAVS N/A
- EPS
- CELU N/A
- PAVS N/A
- Revenue
- CELU $44,590,000.00
- PAVS $71,542.00
- Revenue This Year
- CELU N/A
- PAVS N/A
- Revenue Next Year
- CELU $76.00
- PAVS N/A
- P/E Ratio
- CELU N/A
- PAVS N/A
- Revenue Growth
- CELU 4.45
- PAVS N/A
- 52 Week Low
- CELU $1.00
- PAVS $0.46
- 52 Week High
- CELU $5.22
- PAVS $1.50
- Technical
- Relative Strength Index (RSI)
- CELU 42.49
- PAVS 40.95
- Support Level
- CELU $1.94
- PAVS $0.58
- Resistance Level
- CELU $2.06
- PAVS $0.74
- Average True Range (ATR)
- CELU 0.13
- PAVS 0.12
- MACD
- CELU 0.02
- PAVS -0.02
- Stochastic Oscillator
- CELU 16.47
- PAVS 27.42
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.